secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aurinia Pharmaceuticals Inc. (AUPH)
CIK:        0001600620
Form:       8-K
Filed at:   2022-05-20T23:59:59+00:00
Accession:  0001628280-22-015026
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aurinia shareholders elect all nine board nominees and approve auditor and say-on-pay at 2022 annual meeting
--------------------------------------------------------------------------------

- All nine director nominees elected; for votes ranged from 24.1M (Hagan) to 34.3M (Balakrishnan); broker non-votes 27.9M.
- PricewaterhouseCoopers ratified as independent auditor: 63.3M for, 6.7M against, 2.0M abstain.
- Say-on-pay advisory resolution approved: 33.1M for, 10.5M against, 0.6M abstain; 27.9M broker non-votes.
- Meeting held virtually on May 17, 2022; results reported on May 20, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600620/000162828022015026/0001628280-22-015026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600620/000162828022015026/auph-20220517.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-015026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer